Press Release

Noted Pharmaceutical Compliance Expert Signs On to Develop Quality Training Workshops at AAHP Summit

FOR IMMEDIATE RELEASE Contact: Eric Foxman 513-402-8847 info@aahp.info   MILWAUKIE, Ore., — Homeopathic manufacturers attending the American Association of Homeopathic Pharmacists’ (AAHP) Quality & Safety Summit this summer will gain valuable insight during three sessions developed by George Bernstein, PhD, a well-known compliance expert for both homeopathic and allopathic companies. readm more…

Read More

AAHP Announces Homeopathic Manufacturing Summit to Address New FDA Guidelines

FOR IMMEDIATE RELEASE Contact: Eric Foxman 513-402-8847 info@aahp.info MILWAUKIE, Ore. — This summer, the American Association of Homeopathic Pharmacists (AAHP) will hold its first Summit on Challenges & Solutions in Quality & Safety of Homeopathic Drug Products. Preceded by an inaugural industry reception on June 27 in Baltimore, the intensive readm more…

Read More

AAHP Mourns the Loss of Dr. Peter Fisher

AAHP, along with the global homeopathic community, is shocked and saddened to learn of the tragic and untimely death of Dr. Peter Fisher. A champion of homeopathic medicine, Peter was the director of Research at the Royal London Hospital for Integrated Medicine, Europe’s largest center for integrative medicine. He was readm more…

Read More

Homeopathic Industry Mourns John A. Borneman, III

MILWAUKIE, Ore., July 13, 2018 — The American Association of Homeopathic Pharmacists (AAHP) mourns the loss of an industry legend. John A. (Jack) Borneman, III, grandson of one of the founding members of AAHP, passed away on July 9, 2018. Among the many industry leadership positions he held, Borneman was readm more…

Read More

Homeopathic Manufacturers Campaign Sends 38,000 Letters to Capitol Hill

MILWAUKIE, Ore., June 27, 2018 — As the result of the American Association of Homeopathic Pharmacists’ (AAHP) first grassroots effort, 38,000 letters from consumers and health care providers poured into offices of U.S. senators and representatives this spring. The letter-writing campaign urged Congressional leaders to ask the U.S. Food and readm more…

Read More

AAHP Shares FDA’s Commitment to Protecting Public Health

December 19, 2017 In response to the U.S. Food and Drug Administration’s (FDA) draft guidance on homeopathic drug products released on Monday, December 18, 2017, the American Association of Homeopathic Pharmacists offers the following statement: The American Association of Homeopathic Pharmacists (AAHP) shares the FDA’s commitment to protecting public health and applauds readm more…

Read More

Upcoming Webinar to Highlight Homeopathic Drug Stability

MILWAUKIE, Ore. (Nov. 14, 2017) – The American Association of Homeopathic Pharmacists (AAHP) will host a two-part webinar series on stability studies for homeopathic drug products. Slated for Dec. 4 and Dec. 11, 2017, both from 1:00 – 2:00 p.m. ET, the webinars will be led by Pejman Parhami, senior readm more…

Read More

AAHP Highlights Expanded Homeopathic Drug Manufacturing Best Practices

MILWAUKIE, Ore. (July 20, 2017) – The American Association of Homeopathic Pharmacists (AAHP) recently hosted a webinar on 2017 improvements to the Homeopathic Pharmacopeia of the United States (HPUS). Highlighting new manufacturing best practices in the HPUS—which more than tripled to 175 from 40 in the prior version—the webinar underscored readm more…

Read More

Homeopathic Manufacturers Explore Next-Generation Quality Control

MILWAUKIE, Ore., May 4, 2017 — Member companies of the American Association of Homeopathic Pharmacists (AAHP) gathered to learn about promising new technologies recently used by the U.S. Food and Drug Administration (FDA) to analyze homeopathic products. Developments in this area could lead to industry-wide manufacturing advancements as well as readm more…

Read More